WNT1 and ovarian carcinoma: The results showed that LINC00922 knockdown was significantly decreased the Wnt1 protein expression and β-catenin nuclear expression in SKOV-3 and ES-2 cells compared with those in the control group (Fig. 7), indicating that LINC00922 activated Wnt/β-catenin signaling pathway in ovarian cancer.